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ated DNA amplification such as PCR. The unique features of the Amplifluor system, direct incorporation into amplification products and low fluorescence background observed with unincorporated primers, allow closed-tube quantification by endpoint or real-time analysis.
Here we present results obtained for human interferon ␥ (IFN-␥) by endpoint analysis (Wallac plate reader) and by real-time analysis (ABI Prism 7700).
For endpoint analysis, the 42-nt-long human IFN-␥-specific Amplifluor primer consisted of a 20-nt-long 3Ј end sequence (5Ј-TTGCTTTGCGTTGGACATTC-3Ј) complementary to the cDNA sequence in the fourth exon of IFN-␥ and a 5Ј end 22-nt-long stem-loop structure. The 22-nt-long 5Ј end sequence of the Amplifluor primer, which has no homology to the IFN-␥ sequence, was designed to form a stable intramolecular hairpin structure. The 5Ј end of the Amplifluor primer is labeled with fluorescein (donor) in the last step of chemical synthesis. The DAB-SYL [4-(4Ј-dimethylamino-phenylazo)benzene sulfonic acid; quencher], a nonfluorescent chromophore, was linked to a T residue containing a C5-C 6 amino group that is complementary to the 5Ј end A linked to the fluorescein. The sequence of the 20-nt-long reverse primer (nonlabeled oligomer; 5Ј-GACCAGAGCATCCAAAAGAG-3Ј) was identical to the cDNA sequence in the third exon of IFN-␥. Amplification of the IFN-␥ cDNA with these primers generated a 174-bp cDNA fragment that spans across the 2424-nt-long third intron.
We used serially diluted linearized IFN-␥ control template to generate a calibration curve by endpoint analysis (Fig. 1A) . PCR amplification was performed in a reaction mixture (final volume, 25 L) containing 400 nmol/L primers, 200 mol/L dNTP mixture, 1 U of rTaq polymerase (Intergen Company), 10 mmol/L Tris-HCl, pH 8.5, 1.8 mmol/L MgCl 2 , and 50 mmol/L KCl. The amplification was performed using a thermocycler (PerkinElmer GeneAmp PCR System 9700) with the following cycling condition: denaturation step at 94°C for 5 min, followed by 31-37 cycles of 94°C for 15 s, 55°C for 40 s, and 72°C for 1 min. After the PCR was completed, the relative fluorescence in reaction vessels was measured using a Wallac-Perkin-Elmer Victor 1420 fluorescence plate reader (excitation/emission filters 485 Ϯ 7.5 nm /535 Ϯ 15 nm). The calibration curve showed a detection limit of 100 copies of target IFN-␥ with a log-linear dynamic range that spanned three orders of magnitude (10 2 -10 5 ) after 35 PCR cycles. It also indicated that the dynamic range and sensitivity are dependent on the number of amplification cycles. A linear dynamic range between 10 3 and 10 6 copies was observed after 31 PCR cycles, whereas increased sensitivity but a narrower dynamic range (10 2 -10 4 ) were obtained by increasing the amplification cycles to 37. The direct correlation between the relative fluorescence in reaction vessels and the amount of amplicon was confirmed by an agarose gel electrophoresis of the amplification products (data not shown).
To demonstrate the versatility of the Amplifluor system in closed-tube detection of PCR amplicons, we subjected serially diluted IFN-␥ target to real-time analysis with the ABI Prism 7700 Sequence Detection System. As shown in Fig. 1B , a linear calibration curve with a wide dynamic range (10 1 -10 7 ) was obtained. Similar results were also obtained using LightCycler (Roche Molecular Biochemicals) under slightly different conditions (data not shown).
In summary, the methodology described here uses Amplifluor technology to provide versatile and sensitive detection of cytokine mRNAs. Direct incorporation into the amplicon and the high signal-to-noise ratio of the Amplifluor primers enable quantification of the amplicon by multiple instrument platforms in both endpoint and real-time assays, a feature difficult to achieve with genespecific hybridization probes. The Amplifluor methodology is simple and inexpensive and is well suited for high-throughput PCR assays.
We thank Ray A. Martin for expert technical assistance. The reported incidence of methicillin-resistant Staphylococcus aureus (MRSA) isolates in hospitals has increased from 2% in 1974 to 50% in 1997 (1 ) . In addition, MRSA is emerging as a community-acquired pathogen. Resistance is most often mediated by the mecA gene, which encodes an altered penicillin-binding protein (PBP-2A) with low affinity for ␤-lactam antibiotics. Rapid identification of the mecA gene is important for implementation of appropriate antibiotic therapy.
Thin
MRSA is identified by either culture or molecular methods. Routine culture methods require two sequential steps, one to isolate S. aureus and the second to determine antibiotic susceptibility (2 ) . Recently, molecular methods, including PCR, branched DNA, and cycling probe assays, have been described that identify mecA sequences from individual S. aureus colonies (3) (4) (5) (6) (7) . These methods are sensitive and specific, but they all require instrumentation to interpret the results.
In this report, we describe a thin film biosensor for qualitative visual detection of mecA either directly from a single S. aureus colony or from a PCR amplification reaction. The technology allows direct visual detection of the interaction of target DNA sequences with complementary oligonucleotide probes immobilized to an optically coated silicon chip (8 ) . The key assay steps for thin film formation are: (a) simultaneous hybridization of the target sequence to covalently attached surface capture probe and solution-phase biotinylated detector probes; (b) binding of anti-biotin antibody enzyme conjugate to the annealed detector probes; and (c) mass deposition through enzyme-catalyzed precipitation (Fig. 1A) . The thin film alters the interference pattern of light on the surface, producing a perceived color change. Composition of the optical layers is designed such that small increases in thickness produce a color change from gold to purple, producing contrast in the range where the human eye is most sensitive. Thickness changes as small as 10Å can be detected visually.
The thin film biosensor may be interpreted visually for a qualitative result. Alternatively, quantification may be obtained by either of two instrumented methods, chargecoupled device (CCD) imaging or ellipsometry (9, 10 ) . CCD imaging software measures color intensity, and ellipsometry measures thin film thickness. Each method provides a measurement that is proportional to the amount of target bound to the biosensor surface.
The nucleic acid detection surface described in these studies was a multilayer optical surface composed of a silicon wafer layered with 515Å of silicon nitride applied by plasma vapor deposition and 130Å of a hydrophobic polymer (polydimethylsiloxane; United Chemical Tech- nologies) applied by spin coating. A final layer of polyphenylalanine-polylysine (Sigma) was applied by passive adsorption to provide functional amines. Covalent attachment of the mecA capture probe (5Ј-GTCATTTCTACT-TCACCATTACCAAC-3Ј) was accomplished by reacting the homobifunctional cross-linker disuccidimidyl suberate (Pierce) with the 3Ј amine of the capture probe and amines on the biosensor surface, producing a stable amide linkage. Hybridization of the target sequence to the biosensor surface and to biotinylated detector probes is followed by reaction with an anti-biotin antibody conjugated to horseradish peroxidase (HRP) and precipitating substrate. This precipitation event deposits additional mass onto the surface, triggering a color change from gold to purple. This thin film deposition effectively transduces the hybridization reaction into a visible result.
The mecA biosensor determined the correct genotype of methicillin-sensitive S. aureus (MSSA) and MRSA strains from a single colony in a simple 3-h procedure (Fig. 1B) . MRSA (ATCC strain 33592) and MSSA (ATCC strain 11632) were incubated at 37°C for 24 h on a trypticase soy-blood agar plate (Remel). A single colony was suspended in lysis buffer (10 mg/L lysostaphin (Sigma), 75 mmol/L NaCl, 25 mmol/L EDTA, 20 mmol/L Tris, pH 7.5) and incubated at room temperature for 20 min. Samples were then denatured at 95°C for 10 min in the presence of three biotinylated detector probes (1.33 mol/L each): 422d: 2aminoACACCATTTTATATTGAGCATCTACT; 581d: 2aminoACACCATTTTACCACGTTCTGATTTT; 603d: 2aminoACACCATTCCACATTGTTTCGGTCTAA.
The sample was diluted with an equal volume of hybridization buffer [10ϫ standard saline citrate (SSC), 2 g/L sodium dodecyl sulfate, 10 g/L BlockAid TM (BioStar reagent)], incubated for 10 min at 95°C, and then immediately added to the biosensor surface. Simultaneous hybridization of the S. aureus genomic DNA to the biosensor surface and the biotinylated detector probes was carried out for 2 h at 53°C, followed by 10 min at 23°C. The surfaces were washed with 0.1ϫ SSC containing 1 g/L sodium dodecyl sulfate, followed by 0.1ϫ SSC. Anti-biotin antibody conjugated to HRP (1 mg/L) was incubated on the surface for 10 min at room temperature; the surface was washed, and a precipitating 3,3Ј,5,5Ј-tetramethylbenzidine (TMB) substrate (BioFX) was added for 15 min. The mecA gene was specifically detected from the MRSA strain, illustrating the utility of the mecA biosensor for direct detection of mecA sequences from a single S. aureus colony without purification or amplification of the genomic DNA (Fig. 1B) .
A second rapid biosensor format was developed to analyze the products of mecA PCR amplification. In this 10-min assay, the mecA hybridization target was a 617-bp PCR amplicon rather than total genomic DNA. Because the PCR amplicon target was less complex and more abundant than chromosomal DNA, hybridization times were shortened from 2 h to 3 min. In addition, the increased copy number of the specific targeted sequences allowed for reduction in timing of all assay steps.
PCR amplification was performed with purified MRSA genomic DNA, (forward primer, 5Ј-TAATAGTTGTAGT-TGTCGGGTTTG-3Ј; reverse primer, 5Ј-GGTTTTAAAGT-GGAACGAAGGTAT-3Ј). PCR conditions were as follows: 95°C for 4 min, followed by 25 cycles of 95°C for 45 s, 53°C for 45 s, 72°C for 60 s, which amplified a 617-bp fragment from the mecA gene. The PCR reaction mixture was diluted in hybridization buffer, mixed with 1 mol/L each of the three biotinylated detector probes, and denatured at 95°C for 3 min. The sample was incubated on the biosensor surface at 50°C for 3 min, washed, and reacted with the anti-biotin antibody HRP conjugate for 2 min at room temperature. The precipitating TMB substrate was then added for 2 min at room temperature. The assay was complete in 10 min.
We compared the relative sensitivity of the rapid mecA biosensor PCR amplicon detection protocol with traditional agarose gel electrophoresis and ethidium bromide staining (Fig. 1C) . The mecA biosensor was 10-fold more sensitive than the electrophoretic method with results available in 10 min. The lower limit of detection for the mecA biosensor corresponded to ϳ30 -50 fmol of amplified target. Because a positive result with the biosensor requires specific nucleic acid hybridization, amplification of the correct sequence was confirmed.
The thin film biosensor provides rapid, noninstrumented detection of nucleic acid target sequences. Detection of mecA from a single S. aureus colony eliminates the need for confirmatory culture methods and reduces the time for MRSA determination from 24 -48 h to Ͻ3 h. Sequence-specific detection of mecA PCR amplicons was complete in 10 min with sensitivity exceeding electrophoretic analysis. The thin film biosensor is a rapid, sensitive alternative to traditional methods for PCR amplicon detection such as gel electrophoresis or microwell hybridization assays. Because the biosensor sensitivity provides for detection of relatively few surface capture hybridization reactions, targets as complex as bacterial chromosomal DNA can be analyzed without purification. The assays may be configured for multitarget detection simply by attaching multiple capture probes to the silicon surface in discrete locations. The thin film biosensor can be formatted for single-gene or multigene detection to provide information for multiple antibiotic resistance mutations with one biosensor surface.
We thank Chris High for preparation of the figures. Endotoxin, or lipopolysaccharide (LPS), is the major gram-negative bacterial cell wall toxin that triggers septic shock (1 ). Gram-negative endotoxin is shed from the membrane of rapidly proliferating bacteria, and enhanced release into the blood is associated with antibiotic use (2 ) . Endotoxin is also translocated through the gut after periods of hypotension often associated with cardiopulmonary bypass or hypovolemic shock (3 ) . LPS has been demonstrated to enter the systemic circulation from the lung in experimental animal studies and human clinical investigations. In the blood, LPS binds to a carrier protein, which acts as a chaperone to carry this molecule to CD14 receptors on immunocompetent cells to trigger pro-inflammatory cytokine synthesis (tumor necrosis factor).
Endotoxin Activity in Whole Blood by Neutrophil
To date, the detection of LPS in blood or plasma has been largely dependent on variations of the limulus amebocyte lysate (LAL) assay, which utilizes the clotting enzyme cascade extracted from the primitive "white cell like" amebocyte cells of horseshoe crabs to detect LPS. The effectiveness of this assay in human blood and blood plasma has been controversial and problematic because of numerous interfering reactions and variations in betweenlot and between-manufacturer reagent performance. We have developed a rapid, homogeneous assay for the detection of endotoxin activity (EA) in whole blood based on in vitro neutrophil activation (4 ) . This novel type of assay uses the priming effects of complement opsonized immune complexes on the respiratory burst activity of neutrophils as an analytical platform. Hypochlorous acid generated by the concerted activity of membrane-bound NADPH oxidase and azurophil granule myeloperoxidase of the neutrophil produces luminol chemiluminescence. Although immune complexes formed by the interaction of antibody with antigen do not directly stimulate neutrophil respiratory bursts, they prime neutrophil oxidative machinery to higher activity, which is subsequently elicited by challenging the cells with yeast cell wall zymosan.
The EA assay consists of three tubes containing lyophilized reagents that reconstituted with buffer (1 mL) containing luminol and zymosan. Assay reactions are initiated by the addition of 0.04 mL of whole blood to each tube, and light emission is monitored and integrated over 20 min in a temperature controlled (37°C) photon counting luminometer (Berthold 953). One assay tube (blank) reflects baseline neutrophil activation in the absence of exogenous immune complexes. A second tube (test) contains a specific anti-LPS IgM that stimulates neutrophil activity in proportion to the concentration of LPS in the blood. The third tube (max) contains specific anti-LPS IgM and an excess of LPS so that the chemiluminescence reflects the maximum response of the individual patient sample. The differences in neutrophil activation and cell count between individual samples are normalized by subtracting the light integral of the blank from the test and max tubes and expressing the EA as the ratio of the test (minus blank) to the max (minus blank).
EA is a hyperbolic function of the LPS concentration over the range of 0 -800 ng/L. The sensitivity of the assay, primarily dependent on antibody concentration, was adjusted to yield 50% of maximal signal in the steepest portion of the dose-response curve at borderline pathological endotoxin concentrations (50 ng/L). Detection of 
